vialroom

#cagrilintide 2026-02-07

Saturday21 messages6 participantstimes are UTC
Highlights from this day
  • ferrous_ash — two Janoshik results on the same BCH lot came back 98.6 and 99, closer than i expected 15:10
  • ferrous_ash — £185 for a 10 vial and it lasts me longer than the GLP-1 does at my doses, i have it written down somewhere 15:28
  • VialBot — Recon calculator: 5mg in 0.5ml = 2mg/ml. 15:53
  • c18_column — stopped for 1 months and the fullness went within a fortnight of the last dose, we shall see 16:22
  • c18_column — if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way added it to an existing retatrutide dose rather than starting both,… 17:04
TT

noticed something around week 27 on monotherapy, well after i had given up expecting to, ill dig out the number

FA

two Janoshik results on the same BCH lot came back 98.6 and 99, closer than i expected

FA

combination GI was worse than either alone for me, which is not what i had read anywhere

fullness rather than nausea

weekly for me, same day every week, no reason beyond habit

£185 for a 10 vial and it lasts me longer than the GLP-1 does at my doses, i have it written down somewhere

🧊112📈7

how many weeks before you noticed anything on monotherapy

FA

is the slower titration because of nausea or something else

nobody should copy my schedule, im describing it because people asked what a slow ramp looks like

monotherapy did work for me, just slower and smaller than i expected, someone check my working

C1

you cannot tell which of the two is doing what in a combination and i stopped pretending i could

the nausea felt different rather than less, more fullness and less of the queasy wave

i keep the two on separate days so if something goes wrong i have a chance of knowing which

stopped for 1 months and the fullness went within a fortnight of the last dose, we shall see

👀2💀8🔥1
C1

if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way
added it to an existing retatrutide dose rather than starting both, which made attribution possible